Invitrogen™ Human IFN beta Synthetic Peptide
IFN-beta Synthetic Peptide, PEP-0507, from Invitrogen.
- Gene ID (Enter)
- 3456
- Species
- Human
- Purification method
- Purified
- Accession number
- P01574
- Common name
- Human IFN beta
- Brand
- Invitrogen
IFN-beta Synthetic Peptide, PEP-0507, from Invitrogen.
IFN-beta Synthetic Peptide, PEP-0507, from Invitrogen.
Type I Interferons (IFN-alpha/beta) are produced primarily in response to viral infection by Natural IFN-producing cells (IPCs) as part of the host immune response. IFNs can also inhibit the development of tumors. IFN-beta binding results in the activation of the tyrosine kinases Jak1 and Tyk2, phosphorylation of members of the STAT family of transcription factors, and the transcription and expression of the immune response genes. More recently, several members of the toll-like receptor (TLR) family were found to stimulate the production IFN-beta. IFN-beta is currently used clinically for treatment of tumors, infections and multiple sclerosis.
Species: Human.
Storage: -20°C.
Concentration: 1 mg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15368620 |
| Specifications | |
| Gene ID (Enter) | 3456 |
| Species | Human |
| Purification method | Purified |
| Accession number | P01574 |
| Common name | Human IFN beta |
| Concentration | 1 mg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | IFNB1 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP0507 |
|---|---|
| Country of origin | United States |
| HS customs code | 2934 99 90 00 |